Skip to main content
ARIX BIOSCIENCE PLC logo

ARIX BIOSCIENCE PLC — Investor Relations & Filings

Ticker · ARIX ISIN · GB00BD045071 LEI · 213800OVT3AHQCXNIX43 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2021-05-26 Transaction in Own Shar…
Country GB United Kingdom
Listing IL ARIX

About ARIX BIOSCIENCE PLC

https://www.arixbioscience.com/

Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.

Recent filings

Filing Released Lang Actions
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter is 'Transaction in own shares' and details the purchase of 56,000 ordinary shares as part of a buyback programme. Furthermore, the metadata section at the end of the document explicitly lists 'Category Code: POS'. POS corresponds to 'Transaction in Own Shares (share repurchase/issuance)'. The document is a specific regulatory announcement about share repurchases, not a general regulatory filing (RNS) or a report.
2021-05-26 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states its subject matter in the title and body: "Transaction in own shares" and details the purchase of ordinary shares as part of a buyback programme. The metadata section also includes a 'Category Code: POS' and an 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (Code: POS). Although it is a regulatory announcement disseminated via EQS, the content is specific enough to classify it as POS rather than the general RNS fallback.
2021-05-25 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in own shares' in the title and body. It details the purchase of 59,000 ordinary shares as part of a buyback programme announced on March 22, 2021. Furthermore, the metadata section at the end explicitly lists 'Category Code: POS' and 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (POS).
2021-05-24 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter in the title and body: "Transaction in own shares". It details the purchase of a specific number of ordinary shares as part of a buyback programme, including the date, price, and resulting total shares outstanding. Furthermore, the metadata section explicitly lists the 'Category Code' as 'POS' and the 'OAM Categories' as '2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (POS). The document length is short, but it is the primary announcement itself, not an announcement *about* the announcement.
2021-05-21 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in own shares' as the subject. It details the purchase of a specific number of ordinary shares (63,000) as part of a buyback programme, including the date, price, and settlement details. Furthermore, the metadata section at the end explicitly lists 'Category Code: POS'. POS corresponds to 'Transaction in Own Shares' (share repurchase/issuance). This is a direct match.
2021-05-20 English
Change of registered office
Regulatory Filings Classification · 1% confidence The document is very short (2329 characters) and announces a 'Change of registered office' for Arix Bioscience plc. It is disseminated as a 'Regulatory Announcement' via EQS Group. This type of administrative update, which is not a core financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, SHA, DIRS), fits best under the general category for miscellaneous regulatory disclosures that do not fit elsewhere. According to the definitions, 'Regulatory Filings' (RNS) is the fallback category for general regulatory announcements that do not neatly fit into other specific categories. It is not an announcement of a report publication (RPA) because it is the announcement of an administrative change itself, not the publication of a financial document.
2021-05-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.